Close Menu
    What's Hot

    Sharesify podcast 29 May 2026

    May 29, 2026

    Coming Next Week: CrowdStrike, DiscoverIE and Ulta Beauty

    May 29, 2026

    Dell stock surges after blowout Q1 2027 earnings and massive AI guidance raise

    May 29, 2026
    • Contact Us
    Facebook X (Twitter) Bluesky LinkedIn
    SharesifySharesify
    • Home
    • News
      • Stocks and Shares
      • Investment Trusts
      • ETFs/Funds
      • Premium
      • Research
      • Education
    • Events
      • Upcoming Events
      • Past Events
    • Podcasts
    • Videos
    SharesifySharesify
    Home » News » Animalcare bows to £235 million takeover bid
    News

    Animalcare bows to £235 million takeover bid

    Ian ConwayBy Ian ConwayApril 16, 2026Updated:April 28, 2026No Comments2 Mins Read
    Animalcare bows to £235 million takeover bid
    Animalcare bows to £235 million takeover bid
    Share
    Facebook Twitter LinkedIn Bluesky

    AIM-listed veterinary products firm Animalcare (ANCR) has agreed a takeover by CPP Paw 2, backed by Charterhouse Capital. The cash offer, at 336p per share or a 36% premium to yesterday’s close, values the business at £235.2 million.

    ‘A superior outcome’

    Animalcare said while it was ‘highly confident’ of its standalone prospects, it had received and considered several approaches in recent years. Having evaluated the offer against its growth strategy, the board believes a takeover represents ‘a superior outcome for stakeholders’.

    The group’s aim was to drive revenue growth in the medium term through organic growth, M&A and new products. However, all three strategies require a ‘materially’ higher level of investment than in the past.

    The board concluded the time and investment needed to drive organic growth and finance M&A would be better suited to private equity ownership. Similarly, the ‘intensive’ investment cycle to develop new products and prolonged payback period is also better suited to private ownership.

    For Charterhouse, the appeal is Animalcare’s ‘balanced and focused’ portfolio of products and its geographic coverage across Europe and Australasia. The private equity group has form investing in healthcare and believes it can leverage its experience to help Animalcare grow.

    We haven’t followed Animalcare closely, but porcine vaccine maker Genus (GNS) has most definitely been on our radar. Given nearly half the shareholders are backing this deal, including Harwood Capital with its 18% stake, we can’t see a rival offer emerging.

    In terms of multiple, the £235 million price tag represents over 14 times 2025’s forecast EBITDA of £16 million, which seems punchy. Animalcare did have a 2030 EBITDA target of £37.5 million, though, which would drop the multiple to six times.

    However, bythe firm’s own admission its 2030 targets carried significant risk so we wouldn’t take them that seriously. More broadly, leaving aside the price, this deal means another successful company is exiting the AIM market.

    Read the press release here: https://www.animalcaregroup.com/news/rns/

    You might also like these stories:

    ECO Animal Health boosted by earnings beat
    Genus earnings to beat expectations
    Market snaffles up Genus upgrade

    Disclaimer: This content is for information only and is not investment advice. Always do your own research before investing. Click here to see full disclaimer.
    ANCR Animal Health Animalcare GENUS GNS Healthcare M&A Private Equity Veterinary drugs Vets
    Share. Facebook Twitter LinkedIn Bluesky
    Ian Conway
    • LinkedIn

    Ian Conway has worked in financial markets for over 30 years as a bond and equity trader, Extel-rated analyst and strategist, and partner of a stockbroking firm. He also founded a financial research company servicing institutional clients prior to writing for and editing Shares magazine. Ian admits to supporting 'The Irons' and being a complete petrolhead with several old motors. Find him at LinkedIn: Click Here

    Related Posts

    Sharesify podcast 29 May 2026

    May 29, 2026

    Coming Next Week: CrowdStrike, DiscoverIE and Ulta Beauty

    May 29, 2026

    Dell stock surges after blowout Q1 2027 earnings and massive AI guidance raise

    May 29, 2026
    Add A Comment

    Comments are closed.

    Popular
    Sharesify podcast with Georgina Brittain of JPMorgan UK Small Cap Growth & Income
    News

    Sharesify podcast with Georgina Brittain of JPMorgan UK Small Cap Growth & Income

    By James Crux — May 26, 2026
    ‘Start Investing Now’ part 10: How to research individual stocks for yourself
    ‘Start Investing Now’ part 10: How to research individual stocks for yourself
    May 26, 2026
    Pathos wins largest contract to date
    Pathos wins largest contract to date
    May 26, 2026
    Latest

    Sharesify podcast 29 May 2026

    May 29, 2026

    Coming Next Week: CrowdStrike, DiscoverIE and Ulta Beauty

    May 29, 2026

    Dell stock surges after blowout Q1 2027 earnings and massive AI guidance raise

    May 29, 2026
    European Opportunities Trust is to wind itself up and offer long-suffering shareholders three options

    European Opportunities proposes merger with JEGI

    May 29, 2026
    Sharesify
    Facebook X (Twitter) Bluesky LinkedIn
    • About
    • Terms and Conditions
    • Sharesify Team
    • Privacy Policy
    • Investment Warning
    • Disclaimers
    • Cookie Policy
    • Contact Us
    © 2026 Sharesify
    FinPFC Media (Company number 16868220)

    Type above and press Enter to search. Press Esc to cancel.